Article
Kenvue, the Company Behind Tylenol, Tries to Navigate Its Latest Crisis
Strong Bearish
-100.0
−100 Bearish
0
+100 Bullish
Kenvue, a two-year-old spinoff from Johnson & Johnson, is confronting a public-relations nightmare as President Trump and others suggest unproven links between the pain reliever and autism.
Actions
Pulse AI
Pulse analysis not available yet. Click "Get Pulse" above.
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.
Article Info
Source
New York Times Business
Published
Sep 22, 2025 · 8:10 pm
Article ID
79697150366076012409
Original URL
Open source
Sentiment Signal
Strong Bearish
-100.0
−100Neutral+100
More Like This